News

Angioline Sponsored the XI Annual International Conference Hybrid Technologies in the Treatment of Cardiovascular Diseases

From February 2rd to 4th, the Hybrid Technologies in the Treatment of Cardiovascular Diseases conference (MICHS-2020), one of the leading companies in the field of hybrid and endovascular surgery in Russia, is being held in Moscow. This year the event is attended by both domestic and foreign experts - representatives of such countries as Korea, Israel, Germany, Great Britain, Belarus, Uzbekistan, Lithuania, Sweden, Italy, Hungary. Angioline takes part in the conference as a sponsor. At the corporate stand, the company presents its latest developments: Transcatheter Aortic Valve, Aortic Stent-graft, LAA Occlude. Booth's visitors can study the novelties and ask all questions of interest to Angioline consultants. Traditionally, the conference highlights the most pressing problems and achievements of global invasive cardiology, hybrid and endovascular cardiac surgery. This year, lectures alternate with demonstrations of operations performed by employees of the Hybrid Surgery Laboratory of the NMIC of Cardiology together with foreign colleagues. A joint discussion and study of pressing issues, as well as the exchange of experience between specialists, allows us to identify new ways to solve world health problems.